Seijo Vila M, Balsinde SA, Blasco-Benito S, Tundidor I, Rubert Hernández M, Montero-calle A, Barderas R, Kilpatrick LE, Platt S, Karsai N, Philps I, Antón OM, Gómez Domínguez D, de Castro I, González Lois C, García Fresnadillo D, Silvestre-egea G, Sánchez-López AJ, Ramírez Medina E, Rivas prieto MC, Almoguera Pérez-Cejuela B, Manso L, Zazo S, López Ejeda N, Palomino-duque F, Turienzo Durán M, Martínez Illescas NG, Salazar Roa M, Castillo Lluva S, Hill SJ, Guzman M, Perez Gomez E, Sanchez C
*.
Cannabinoid CB(2) receptor drives trastuzumab resistance and predicts durable anti-HER2 response. Oncogene 2026; 45(25): 2436-2451.
